Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb 1;30(3):1-8.
doi: 10.1111/dote.12470.

Newly developed and validated eosinophilic esophagitis histology scoring system and evidence that it outperforms peak eosinophil count for disease diagnosis and monitoring

Affiliations

Newly developed and validated eosinophilic esophagitis histology scoring system and evidence that it outperforms peak eosinophil count for disease diagnosis and monitoring

M H Collins et al. Dis Esophagus. .

Abstract

Eosinophilic esophagitis (EoE) is diagnosed by symptoms, and at least 15 intraepithelial eosinophils per high power field in an esophageal biopsy. Other pathologic features have not been emphasized. We developed a histology scoring system for esophageal biopsies that evaluates eight features: eosinophil density, basal zone hyperplasia, eosinophil abscesses, eosinophil surface layering, dilated intercellular spaces (DIS), surface epithelial alteration, dyskeratotic epithelial cells, and lamina propria fibrosis. Severity (grade) and extent (stage) of abnormalities were scored using a 4-point scale (0 normal; 3 maximum change). Reliability was demonstrated by strong to moderate agreement among three pathologists who scored biopsies independently (P ≤ 0.008). Several features were often abnormal in 201 biopsies (101 distal, 100 proximal) from 104 subjects (34 untreated, 167 treated). Median grade and stage scores were significantly higher in untreated compared with treated subjects (P ≤ 0.0062). Grade scores for features independent of eosinophil counts were significantly higher in biopsies from untreated compared with treated subjects (basal zone hyperplasia P ≤ 0.024 and DIS P ≤ 0.005), and were strongly correlated (R-square >0.67). Principal components analysis identified three principal components that explained 78.2% of the variation in the features. In logistic regression models, two principal components more closely associated with treatment status than log distal peak eosinophil count (PEC) (R-square 17, area under the curve (AUC) 77.8 vs. R-square 9, AUC 69.8). In summary, the EoE histology scoring system provides a method to objectively assess histologic changes in the esophagus beyond eosinophil number. Importantly, it discriminates treated from untreated patients, uses features commonly found in such biopsies, and is utilizable by pathologists after minimal training. These data provide rationales and a method to evaluate esophageal biopsies for features in addition to PEC.

Keywords: eosinophilic esophagitis; pathology; pediatrics; scale.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
EoE biopsies. (A) EI is present (arrows). BZH (bar) occupies >66% of total epithelial height (grade 3). Intercellular bridges in DIS (arrowheads) are easily identified at 100X (grade 3). LPF fibers exceed the diameter of basal cell nuclei (asterisks) (grade 3). (B) EA (white asterisk) contains more than 20 eosinophils (grade 3). SL (arrows) consists of 5–10 eosinophils in a row (grade 2). DIS are present (arrowheads).
Fig. 2
Fig. 2
EoEHSS feature frequency. Frequency of histologic abnormalities in untreated (black bars) and treated (gray bars) in distal (A) and proximal (EoE) biopsies (B). *P ≤ 0.05, **P ≤ 0.0063 (Bonferroni multiple testing threshold).
Fig. 3
Fig. 3
Correlations between features. Panels A–D exhibit heatmaps of the Spearman correlations; A distal grade, B proximal grade, C distal stage, D proximal stage. Darker colors indicate higher correlation coefficients.

References

    1. Furuta G T, Liacouras C A, Collins M H et al. . Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007; 133: 1342–63. - PubMed
    1. Liacouras C A, Furuta G T, Hirano I et al. . Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011; 128: 3–20. - PubMed
    1. Dellon E S, Gonsalves N, Hirano I, Furuta G T, Liacouras C A, Katzka D A. ACG clinical guideline: evidence based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol 2013; 108: 679–92. - PubMed
    1. Konikoff M R, Noel R J, Blanchard C et al. . A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology 2006; 131: 1381–91. - PubMed
    1. Assa'ad A H, Gupta S K, Collins M H et al. . An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis. Gastroenterology 2011; 141: 1593–604. - PubMed

Publication types